Qrons Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QRON research report →
Companyqrons.com
Qrons Inc. , a biotechnology company, engages in development of biotech products, treatments, and technologies to combat neuronal diseases. Its product candidates include QS100, an injury specific, 3D printable, implantable mesenchymal stem cells (MSCs)-synthetic hydrogel to treat penetrating brain injuries; and QS200, an injectable MSCs-synthetic hydrogel for the treatment of concussions and other diffused axonal injuries.
- CEO
- Cory J. Rosenberg
- IPO
- 2017
- Employees
- 10
- HQ
- Long Island City, NY, US
Price Chart
Valuation
- Market Cap
- $199.80K
- P/E
- -2.75
- P/S
- 0.00
- P/B
- -0.35
- EV/EBITDA
- -1.44
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 5.80%
- ROIC
- 236.10%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-56,097 · 92.89%
- EPS
- $-0.00 · 93.14%
- Op Income
- $-344,000
- FCF YoY
- 10.03%
Performance & Tape
- 52W High
- $0.17
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.06
- Beta
- 1.04
- Avg Volume
- 83
Get TickerSpark's AI analysis on QRON
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Dec 22, 22 | Merfeld Ido | other | 325,000 |
| Dec 22, 22 | Meer Jonah | other | 325,000 |
| Dec 22, 21 | Merfeld Ido | other | 325,000 |
| Dec 22, 21 | Meer Jonah | other | 325,000 |
| Dec 10, 20 | Merfeld Ido | other | 325,000 |
| Dec 10, 20 | MEER JONAH | other | 325,000 |
| Dec 17, 19 | Merfeld Ido | other | 325,000 |
| Dec 17, 19 | MEER JONAH | other | 325,000 |
| Jul 1, 19 | BONFIGLIO JOHN N | other | 0 |
| Jul 1, 19 | BONFIGLIO JOHN N | other | 100,000 |
Our QRON Coverage
We haven't published any research on QRON yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QRON Report →